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Reduced Apoptosis and Cytochrome c±Mediated
Caspase Activation in Mice Lacking Caspase 9
Once activated, caspases cleave a host of cellular sub-
strates, leading to morphological hallmarks of apoptosis
including DNA fragmentation and condensation of cellu-
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Six lines of caspase-deficient mice that have beenCambridge, Massachusetts 02139
recently generated (Caspases 1, 2, 3, and 11 knockouts)²Section of Neurobiology
all exhibit cell death abnormalities, indicating that cas-Yale University Medical School
pases play an important role in apoptosis (Kuida etNew Haven, Connecticut 06510
al., 1995, 1996; Li et al., 1995; Bergeron et al., 1998;³Section of Immunobiology
Wang et al., 1998; Woo et al., 1998). Interestingly, theseHoward Hughes Medical Institute
knockouts do not exhibit a global suppression of cellYale University Medical School
death, but rather tissue- and cell type±specific or stimu-New Haven, Connecticut 06510
lus-dependent defects of apoptosis. The preferential§Tokyo Metropolitan Institute of Medical Science
apoptosis defects suggest that different sets of cas-3-18-22 Honkomagome
pases are involved in separate cell death pathways inBunkyo-ku, Tokyo 113
vivo. In addition, phenotypes of variable severities wereJapan
found in two independent lines of Caspase 3±deficient
(Casp32/2) mice, in which the majority of homozygous
embryos die in utero, while some mutants survive to 4±5
Summary weeks of age (Kuida et al., 1996; Woo et al., 1998). The
variability of phenotypes suggests the involvement of
Caspases are essential components of the mamma- additional components, such as the recently reported
lian cell death machinery. Here we test the hypothesis inhibitor-of-apoptosis (IAP) family of suppressors (De-
that Caspase 9 (Casp9) is a critical upstream activator veraux et al., 1997), in modifying the apoptotic response.
of caspases through gene targeting in mice. The ma- One important issue to be elucidated concerns the
jority of Casp9 knockout mice die perinatally with a mechanism of activation of the caspase cascades. A
markedly enlarged and malformed cerebrum caused well-understood mechanism is the assembly of a signal-
by reduced apoptosis during brain development. Casp9 ing complex at the CD-95 (Fas/Apo-1) receptor, which
deletion prevents activation of Casp3 in embryonic in turn leads to the autoproteolytic activation of Caspase
brains in vivo, and Casp9±deficient thymocytes show 8 (Casp8) (Nagata, 1997; Muzio et al., 1998; Yang et al.,
resistance to a subset of apoptotic stimuli, including 1998). Another recently discovered mechanism involves
absence of Casp3±like cleavage and delayed DNA the release of cytochrome c from the mitochondria,
fragmentation. Moreover, the cytochrome c±mediated which subsequently causes apoptosis by activation of
cleavage of Casp3 is absent in the cytosolic extracts caspases (Kluck et al., 1997; Reed, 1997; Yang et al.,
of Casp9±deficient cells but is restored after addition 1997). It remains to be clarified whether, or at which
of in vitro±translated Casp9. Together, these results step during apoptosis, these two pathways converge.
indicate that Casp9 is a critical upstream activator of In a series of biochemical studies on the initiation of
the caspase cascade in vivo. Casp3 cleavage in HeLa cells, it was discovered that
the apoptotic protease activating factors (Apafs) include
cytochrome c released from the mitochondria (Apaf-2),Introduction
the human homolog of Ced-4 (Apaf-1), and the Caspase
9 proenzyme (Casp9) (Apaf-3) (Liu et al., 1996; Li et al.,Apoptosis, or programmed cell death (PCD), is an impor-
1997; Zou et al., 1997). The amino terminal sequencestant mechanism of maintaining homeostasis during de-
of Casp9 and Apaf1 both contain a caspase recruitmentvelopment and for responses to external stimuli in multi-
domain (CARD) motif that is indispensible for their inter-cellular organisms (Glucksmann, 1951; Kerr et al., 1972;
actions (Hofmann et al., 1997; Li et al., 1997). Casp3,Jacobson et al., 1997). Recent studies indicate that the
which lacks the CARD domain, does not bind to Apaf1.fundamental apoptosis machinery, which consists of
In addition, active site mutationsof Casp9 serve as dom-distinct effectors, inhibitors, and initiators, has been
inant-negative influences on the activation of Casp3 inconserved throughout evolution (Ellis et al., 1991; Yuan
transfected cells (Li et al., 1997). Together, these dataet al., 1993; Hengartner and Horvitz, 1994). The key apo-
suggest a linear and specific activation cascade be-ptosis effectors in mammals are a family of cysteine-
tween Casp9 and Casp3 in response to cytochrome ccontaining, aspartate-specific proteases called cas-
released from the mitochondria. Cytochrome c±medi-pases (Alnemri et al., 1996; Nicholson and Thornberry
ated Casp3 activation may be utilized by a specific andet al., 1997). Caspases exist as dormant proenzymes in
restricted set of external apoptosis stimuli. Alternatively,healthy cells and are activated through proteolysis.
since many types of cellular insults all damage mito-
chondria, causing release of cytochrome c into the cyto-
plasm, and since activated Casp3 can directly initiate‖ These authors contributed equally to this work.
# To whom correspondence should be addressed. certain caspase-activated deoxyribonucleases (Liu et
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al., 1997; Enari et al., 1998), the cytochrome c±mediated Table 1. Genotyping of Mice Derived from Caspase 9
caspase activation may serve as an amplification mech- Heterozygous Breeding
anism during most forms of apoptosis.
Genotype 1/1 1/2 2/2
Although in vitro biochemical studies suggest that
E10.5 3 7 3 (23%)Casp9 may be a key element of the cytochrome c±medi-
E12.5 5 3 6 (43%)ated caspase activation, this has not been tested in vivo.
E13.5 10 15 5 (17%)To test this hypothesis, we have generated Casp9 null
E15.5 9 13 6 (21%)
mutation mice by gene targeting. Here we report that E16.5 7 19 9 (26%)
the majority of homozygous mutants die perinatally with P5-P20 160 246 11 (2.6%)
markedly enlarged cerebrum, caused by a reduction of
The genotype of mice at indicated embryonic (E) or postnatal (P)
apoptosis at an earlier stage of brain development. In day were determined by PCR analysis. Wild-type, heterozygous,
contrast, the loss of Casp9 does not affect morphologi- and homozygous animals are indicated as 1/1, 1/2, and 2/2,
cal developments of the spinal cord and other nonneural respectively.
tissues. Despite normal development of the thymus, iso-
lated thymocytes are nevertheless resistant to a subset
of apoptosis stimuli and exhibit delayed DNA fragmenta-
loss of Casp9 results in perinatal lethality. Althoughtion. We show that these Casp9 null mutation pheno-
Casp92/2 fetuses were collected at a Mendelian ratiotypes, which resemble the Casp3 deficiency, are indeed
up to embryonic day (E) 16.5, only less than 3% of theassociated with defective activation of Casp3 in vivo.
total number of genotyped newborn pups were homozy-Furthermore, we show that the cytochrome c±mediated
gous Casp9 mutants (Table 1). No apparent histologicalcleavage of Casp3 is absent in cytosolic extracts from
abnormalities were noticed in a survey of various tissuesCasp9±deficient cells but is restored after reconstitution
in these few postnatal Casp9 mutants.with in vitro±translated Casp9. Taken together, these
results indicate that Casp9 is a key activator of the
Caspase 9 Is Widely Expressed duringcaspase cascade, important for normal brain develop-
Mouse Embryogenesisment and apoptotic responses in thymocytes in vivo.
The observed perinatal lethality indicates that Casp9
plays an important role during development. To testResults
this possibility, we first examined the expression of
Casp9 and its potential associating factors, Apaf1 andNull Mutation of Caspase 9 Causes
Casp3, throughout development. Northern blot analysisPerinatal Lethality
of poly(A)1 RNA isolated from different stages of wild-To generate Casp9±deficient mice, a targeting vector
type embryosrevealed an expression of these apoptosisthat contains a neo gene cassette flanked by 7 kb of the
effectors during early embryogenesis (Figure 1D). Ex-mouse Casp9 genomic sequence was used to replace a
pression of Casp9 mRNA was detected as early as E7,1.0 kb endogenous fragment encoding the conserved
and both Casp3 and Apaf1 transcripts were up-regu-pentapeptide (QACGG) motif common to all caspases
lated at E11 and continuously expressed thereafter. To(Figure 1A). Linearized construct was electroporated
examine the tissue distribution pattern of Casp9, weinto W9.5 ES cells, and transfectants were selected by
extracted total RNA from different organs of E17.5 fe-G418 and gancyclovir. One homologous recombinant
tuses for RT-PCR detection of the expression of Casp9clone, confirmed by Southern blotting analysis, was ob-
transcripts (Figure 1C). Casp9±specific bands were de-tained and injected into C57BL/6 blastocysts to gener-
tected in all tissues examined, indicating a widespreadate chimeras, which were then crossed to C57BL/6 mice
expression pattern of Casp9 during prenatal devel-to generate heterozygous Casp9 mutants. Heterozygous
opment.mice were crossed to generate homozygous Casp9±
deficient (Casp92/2) mice. RT-PCR analysis using total
RNA from Casp92/2 mice confirmed the absence of ex- Caspase 9 Deficiency Causes Severe
Brain Malformationpression of Casp9 mRNA (Figure 1B). Genotyping of
more than 500 fetuses and newborn pups derived from The most conspicuous phenotype of Casp92/2 individu-
als is a severe malformation of the brain. At the grossinterbreeding of heterozygous mice established that the
Figure 1. Targeting Construct and Homologous Recombination at the Caspase 9 Locus and Expression of Caspase 9 mRNA
(A) Targeting construct and restriction map of the Casp9 locus. The restriction map of the wild-type allele, targeting construct, and the mutated
allele are shown. The orientation of the neo cassette is indicated by an arrow. The diagnostic probe used for Southern blot analysis is shown
as a black box.
(B) RT-PCR analysis of Casp9 mRNA. Total RNA was isolated from the kidney of wild-type or Casp92/2 mice and reverse-transcribed. The
resulting cDNA was used for PCR analysis using specific primers for Casp9 or for the g-actin gene. An 860 bp band is amplified by Casp9-
specific primers, and the 700 bp band represents mRNA for g-actin. lHindIII and φX174 HaeIII were used as molecular weight markers (MW).
(C) RT-PCR analysis of Casp9 mRNA expression in various embryonic tissues. One microgram of total RNA from E17.5 fetuses was reverse-
transcribed and subjected to PCR analysis using specific primers for Casp9 or for the g-actin gene. The specific band for Casp9 is detected
in all tissues examined.
(D) Northern blot analysis of Casp9, Apaf1, and Casp3. Blots containing Poly(A)1 RNA isolated from mouse embryos were hybridized with
specific probes for Casp9, Apaf1, and Casp3 genes. Expression of Casp9 mRNA is detected as early as E7, while both Casp3 and Apaf1
mRNA are up-regulated at E11 and expressed thereafter.
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involving apoptosis, is completed in mutant embryos by
E13.5 (insets in Figures 2C and 2D), according to the
normal developmental schedule (Kaufman, 1992).
At the histological level, Casp92/2 embryos exhibited
prominent and ubiquitous enlargement of the prolifera-
tive zone in both the forebrain and midbrain, as well as
stenosis of the cerebral ventricles. At E13.5, an ex-
panded proliferative population, indicated by the dark
Nissl staining, was evident in the telencephalon, with
both the lateral and third ventricles obstructed in the
mutants (Figures 3A and 3B). In addition, heterotopias
and discontinuities of the proliferative ventricular zone
were evident in the mutant telencephalon, leading to
invagination and complete interruption of the telence-
phalic wall (Figures 3C and 3D). By E16.5, the develop-
ment of the mutant brain was markedly altered, with
an expanded midbrain protruding and displacing the
telencephalic vesicles (Figures 3E and 3F). In contrast,
despite the widespread expression of Casp9 during em-
bryogenesis, thespinal cord and other nonneural organs
such as heart and lung were largely normal without mor-
phological alterations in the E16.5 mutants (Figures 3G
and 3H). Thus, the absence of Casp9 results in brain-
specific malformations.
Brain Malformations in Caspase 9±Deficient Mice
Are Caused by Reduced Apoptosis
Apoptosis is a prominent feature during early develop-
ment of the nervous system (Glucksmann, 1951; Oppen-
heim, 1991). If the loss of Casp9 prevents the death
of early stem cells, this would conceivably lead to the
observed enlargement of proliferative zones at a later
stage of development. To test this possibility, we used
two independent approaches to compare the extent of
cell death during brain development between Casp9
homozygous and heterozygous mutants. In the first ap-
proach, we used serial toluidine blue±stained semithin
sections to compare the incidence of pyknotic clusters
Figure 2. Gross Morphological Examination of Caspase9 Heterozy- in theE10.5 neuroepithelium (Figures4A±4D). In addition
gous and Homozygous Fetuses to a greatly enlarged telencephalic neuroepithelial wall,
Embryos were isolated from heterozygotes (left) and knockouts Casp92/2 embryos were characteristically devoid of
(right) at E10.5 ([A] and [B]), E13.5 ([C] and [D]), and E16.5 ([E] and pyknotic clusters, which are typically observed during
[F]), respectively. At E10.5 and E13.5, a defect at the midbrain/
normal brain development (Kallen, 1955). For example,hindbrain junction is evident in the (2/2) mutants (arrowhead). At
pyknotic clusters in the lamina terminalis of the fore-E13.5, the retraction of interdigital webbing caused by morphoge-
brain, which signifies the process of morphogenetic cellnetic cell death is completed in both Casp92/2 mutant and control
littermates [insets in (C) and (D)]. By E16.5, there is protrusion of death that eventually separates the two cerebral hemi-
the larger and morphologically abnormal brain in knockouts. Bar, spheres, were eliminated in the mutant embryo, with the
1 mm. resulting lamina thicker and increased in the number
and density of cells (Figures 4C and 4D). In the second
approach, we used TUNEL staining to detect apoptoticmorphological level, a defect of neural tube closure in
the hindbrain region was apparent in the E10.5 mutants cells in theembryonic brain. A nearly 10-fold reduction of
the average number of TUNEL-positive cells per section(Figures 2A and 2B). At E13.5, the hindbrain neural tube
remained open, and there was an appreciable expansion was found in the E12.5 brain in Casp9 knockouts (Figure
4G). Together, these two sets of data indicated a reduc-of the midbrain region underneath the fetal skin tissue
(Figures 2C and 2D). By E16.5, there was prominent tion of cell death during early brain development in
Casp92/2 mice.expansion and protrusion (exencephaly) of the entire
cranial tissues (Figures 2E and 2F). In addition, the pro- We also used TUNEL staining to compare the extent
of cell death during development of the spinal cord,truding brain masses were enlarged and irregular on the
surface. No gross malformations are found in other parts which revealed no apparent structural alterations in the
Casp92/2 mutants. At E12.5, only a few TUNEL-positiveof the fetal body. For example, the retraction of the
interdigital webbing in the fetal hand plate, a process cells were found in both Casp92/2 and heterozygous
Reduced Apoptosis in Caspase 9±Deficient Mice
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Figure 3. Histological Analysis of Caspase 9
Heterozygous and Homozygous Fetuses
Nissl-stained sections are from (1/2) (left)
and (2/2) (right) fetuses at E13.5 (A±D), and
E16.5 (E and F).
(Aand B) Coronal brain sectionsat E13.5 illus-
trate the larger diencephalon, obliterated lat-
eral and third ventricles, and the interrupted
and invaginated telencephalic wall in knock-
out fetuses.
(C and D) At higher magnification, the telence-
phalic wallof the knockout still shows genesis
of the superficial postmitotic telencephalic
layers, the intermediate zone, and cortical
plate.
(E and F) At E16.5 in a caudal brain section,
the knockout brain has an increased number
of proliferative cells (seen as dark staining),
as well as protrusion of the midbrain on top
of the brain. The (2/2) section (F) illustrates
a proliferative region (star) in this ectopic mid-
brain.
(G and H) Horizontal sections through the
body of the fetuses at the level of the pulmo-
nary artery show that the size and structure
of the spinal cord, lungs, and heart remain
largely unaffected in the (2/2) fetuses. Bar,
1 mm.
littermate neural tubes (Figure 4G). Although the number Caspase 9 Is Required for Activation
of Caspase 3 In Vivoof TUNEL-positive cells was reduced in the Casp92/2
spinal cord at E16.5, no obvious histological abnormali- The brain-specific malformations caused by the reduc-
tion of developmental apoptosis in Casp9±deficientties were found (Figures 4E and 4F). Nevertheless, fur-
ther studies are required to determine whether the re- mice are strikingly similar to the phenotype of the Casp3
null mutation (Kuida et al., 1996). The similarity of pheno-duction of the late onset cell death in the spinal cord may
produce an increased number of neurons in Casp92/2 types indicates that Casp9 and Casp3 may participate in
the same biological pathway during brain development.mutants.
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Furthermore, this is consistent with the scenario that by TUNEL/FACS staining (data not shown). Together,
these results indicate that Casp9 is selectively involvedCasp9 is an upstream activator of Casp3 (Li et al., 1997).
To test this possibility, we used the recently character- in the degradation of DNA during apoptosis of thymo-
cytes in response to defined stimuli.ized CM1 antibody, which only recognizes the cleaved
17 kDa subunit and not the 32 kDa proenzyme of Casp3
(A. Srinivasan et al., submitted), for in situ immunodetec- Caspase 9 Is Required for Caspase 3±like
Cleavage Activity in Distinct Apoptotiction of the cleavage and activation of Casp3 in embry-
onic brains. In E12.5 wild-type and heterozygous em- Pathways of Thymoctes
Recent studies have indicated that Casp3 is a directbryos, CM1-stained cells were found sporadically in the
brain and the ectodermal surface (Figure 5A). Under high upstream activator of certain deoxyribonucleases re-
sponsible for DNA fragmentation during apoptosis (Liumagnification, staining for activated Casp3 was present
both in the cytoplasm and in the condensed nucleus et al., 1997; Enari et al., 1998). Therefore, the observed
resistance to apoptosis and delayed DNA degradation(data not shown). In contrast, although CM1-stained
cells were seen in the meningeal and ectodermal sur- in thymocytes may be caused by the compromised acti-
vation of Casp3 in the absence of Casp9. To test thisfaces, no such staining was found in the brain of all
Casp92/2 mutants, regardless of the severity of brain possibility, we analyzed the survival of thymocytes and
the cleavage of a DEVD-specific fluorescent substratemalformations (Figures 5B and 5C). These results there-
fore indicate that Casp9 is required for activation of after a 6 hr treatment of increasing concentration of
etoposide, dexamethasone, g-radiation, and anti-FasCasp3 in the developing brain in vivo.
antibody (Figure 7). Although etoposide, dexametha-
sone, and g-radiation all induced a steady dose-depen-Caspase 9 Is Required for Apoptotic Responses
to Defined Stimuli in Thymocytes dent increase of cell death and DEVD-specific cleavage
in wild-type thymocytes, none of these reagents wasTo investigate the role of Casp9 in nonneuronal tissues,
we focused on the study of the development and apo- capable of initiating an appreciable Casp3±like activity
in Casp92/2 thymocytes. In great contrast, anti-Fas anti-ptotic response of thymocytes. The development of the
thymus in Casp92/2 mice appeared to be largely normal, body induced a linear increase of Casp3±like activity
and a concomitant progression in cell death in bothwith an equal total number of cells and a comparable
ratio of CD4- and CD8-positive thymocytes compared wild-type and Casp92/2 thymocytes. Together, these
results show that Casp9 is required for Casp3 activa-to wild-type mice (Figure 6A). Primary cultures of wild-
type and Casp9±deficient thymocytes were then chal- tion and apoptosis in response to many stimuli, but,
notably, that Casp9 is not required for either process inlenged with a variety of apoptotic stimuli and assayed
for cell survival by FACS analysis after 6 and 24 hr of response to Fas.
treatment (Figure 6B). At both 6 and 24 hr after stimula-
tion, Casp92/2 thymocytes showed increased cell sur- Caspase 9 Is Essential for Cytochrome c±Mediated
Activation of Caspase 3vival in response to application of anti-CD3 plus anti-
CD28 antibody (which mimics the physiologic activation Our results indicate that Casp9 is an upstream activator
of Casp3 in both the nervous system (Figure 5) and inof T cell receptors), etoposide, g-radiation, and dexa-
methasone. In contrast, Casp92/2 and wild-type thymo- thymocytes (Figure 6) in vivo. This observation is consis-
tent with the recent discovery of the requirement ofcytes were equally susceptible to Fas-mediated apo-
ptosis. Casp9 for cytochrome c±mediated activation of Casp3
(Li et al., 1997). To further test the necessity of Casp9The preferential resistance to apoptotic stimuli corre-
lated with delayed DNA fragmentation in Casp92/2 thy- for caspase activation cascades, we analyzed the cleav-
age of in vitro±transcribed and ±translated humanmocytes (Figure 6C). Although DNA fragmentation in-
duced by etoposide, dexamethasone, and g-radiation CASP3, using 100,000 g cytosolic supernatants (S-100)
of the embryonic brain or thymocytes in the presence ofwas evident at 6 hr and persisted till 24 hrafter treatment
in wild-type thymocytes, such DNA laddering occurred dATP, cytochrome c, or both (Figure 8A). In accordance
with a previous report using HeLa cell extracts, we con-in Casp92/2 thymocytes only after prolonged (24 hr)
treatment with these reagents. In contrast, anti-Fas anti- firmed that cytochrome c was indispensable for the
cleavage of Casp3 using wild-type embryonic tissuebody was equally effective in inducing DNA fragmen-
tation in thymocytes of both genotypes, presumably lysates, although in our case the addition of dATP was
not necessary for the reaction (Liu et al., 1996). Thethrough a Casp9±independent pathway. Identical re-
sults were obtained when DNA cleavage was analyzed latter discrepancy is presumably due to a difference of
Figure 4. Decreased Apoptosis in the Embryonic Brain of Caspase 9±Deficient Mice
Controls are from heterozygous embryos (A, C, and E), and homozygous littermates (B, D, and E) are used for comparison.
(A and B) Toluidine blue±stained horizontal sections of E10.5 embryos reveal the enlarged neuroepithelium and ventricular stenosis in the
mutant (B). The boxed regions in (A) and (B) are shown at higher magnification in (C) and (D), respectively.
(C and D) High-power magnification of the lamina terminalis illustrates pyknotic cells (arrowheads) that are found in heterozygous controls
(C) but are absent in the knockout (D).
(E and F) TUNEL staining of E16.5 thoracic spinal cord indicates a reduced number of apoptotic cells in the mutant (F).
(G) Quantitation of TUNEL-positive cells per section, averaged from 3 littermate pairs each, in the E12.5 brain and E12.5 neural tube (NT) and
E16.5 spinal cord (SC) in heterozygous controls (black bar) and Casp92/2 individuals (white bar). Asterisk, p , 0.05.
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(Figure 8B). Together, these data establish that Casp9
is required for cytochrome c±mediated activation of
Casp3.
Discussion
Although the caspase family of proteases are implicated
as essential components of the mammalian cell death
machinery, the large number of members of the caspase
family, their overlapping tissue distribution, and similar
cleavage specificities altogether present great chal-
lenges for distinguishing the function of individual cas-
pases in vivo. There are two fundamental questions re-
garding the relationship of the caspase family members.
First, are caspases functionally redundant? Second, is
any single caspase indispensable for the activation of
other caspases? The fact that different lines of caspase-
deficient mice (Caspases 1, 2, 3, and 11 knockouts)
all exhibit preferential apoptosis defects rather than a
global suppression of cell death indicates that individual
members of the caspase family play a dominant and
nonredundant role in apoptosis in a tissue-selective or
stimulus-specific manner (Kuida et al., 1995, 1996; Li et
al., 1995; Bergeron et al., 1998; Wang et al., 1998; Woo
et al., 1998). The present study addresses the second
question, regarding the activation cascade of caspases.
Our results demonstrate a linear and essential activation
cascade from Casp9 to Casp3 in vivo. In addition, it
reveals the importance of this caspase cascade in brain
development, in apoptosis of thymocytes, and in the
cytochrome c±mediated caspase activation.
Caspase 9 to Caspase 3 Cascade
The first indication that Casp9 and Casp3 act along the
same biological pathway was the similar phenotypes of
mutant mice lacking either of these two caspases. Both
Casp9 and Casp3 knockout mice have prominent brain
malformations caused by a reduction of apoptosis in
proliferative neuroepithelium (Figures 2±4; Kuida et al.,
1996). Moreover, similar defects of DNA fragmentation
were found in both Casp9± and Casp3±deficient mice
(Figure 6C; Woo et al., 1998). One intriguing possibility
to account for the similar phenotypes is a linear and
obligate proteolytic cascade, since the optimal cleavageFigure 5. In Situ Immunodetection of Activated Caspase 3 in Embry-
motif of Casp9 matches the activation sites of Casp3onic Brains
(Thornberry et al., 1997). To test this hypothesis, weE12.5 brain tissues from wild-type (A) and homozygous mutant lit-
termates (B and C) were stained with the CM1 antibody specific for employed in situ immunodetection of processed Casp3
the p17 subunit of the activated Casp3. subunits in embryonic mutant brain (Figure 5) and mea-
(A) PositiveCM1 staining was found both in the brainand ectodermal surement of Casp3±like activity in thymocytes, using the
surface in the wild-type embryo.
fluorescent DEVD-specific substrate (Figure 7). Defec-(B and C) Positive CM1 staining was detected only in the ectodermal
tive activation of Casp3 in vivo was revealed by bothsurface (arrowheads), but not in the Casp92/2 mutant embryos pos-
approaches. Together, these results establish a linearsessing either severe (B) or mild (C) brain malformations.
and essential activation cascade from Casp9 to Casp3
in vivo.
intracellular dATP concentration between HeLa cells
and embryonic tissues. Nevertheless, lysates of Casp92/2 Role of Caspase 9 in Brain Development
Our results indicate that Casp9 may regulate the numbertissues were not capable of initiating the cleavage of
Casp3, even in the presence of both dATP and cyto- of neuroepithelial progenitor cells during brain develop-
ment. The entire population of cells in the vertebratechrome c (Figure 8A). Furthermore, the addition of in
vitro±transcribed and ±translated human CASP9 back telencephalon are derived from neuroepithelial progeni-
tors located in the proliferative ventricular zones. Duringinto S-100 cytosolic extracts from mutant tissues re-
stored Casp3 processing capability, indicating that all development, the progeny of these progenitors exit the
cell cycle, become postmitotic neurons, and migrateother required elements were present in Casp92/2 cells
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Figure 6. Reduced Apoptotic Responses to Defined Stimuli in Caspase 92/2 Thymocytes
(A) Flow cytometric analysis of thymocytes in wild-type (WT) and Casp92/2 (KO) mice. One million cells were stained with anti-CD4 and -CD8
antibodies and analyzed by FACS. The percentage of each fraction in a total of five animals was quantified. DN (double negative), CD42CD82;
DP (double positive), CD41CD81.
(B) Cell survival analyzed by FACS of FITC-labeled Annexin V and 7-ADD stained thymocytes from wild-type (black bar) and Casp92/2 (white
bar) mice after 6 hr or 24 hr of treatment with various reagents in 10% FCS medium. MED, medium alone; CD3/28, 20 mg/ml each of anti-
CD3 and anti-CD28 antibody; ETO, 100 mM etoposide; RAD, 1000 rad g-radiation; DEX, 2 mM dexamethasone; FAS, 1 mg/ml anti-Fas
antibody plus 30 mg/ml cycloheximide. Casp92/2 thymocytes are significantly resistant to the challenge of anti-CD3 plus anti-CD28 antibody,
dexamethasone, etoposide, and g-radiation, but equally susceptible compared to controls to Fas-induced apoptosis.
(C) DNA fragmentation in wild-type (WT) and Casp92/2 (KO) thymocytes at 6 hr and 24 hr of the same treatment as in (B). Casp92/2 thymocytes
show delayed DNA laddering after application of anti-CD3 plus anti-CD28 antibody, etoposide, dexamethasone, and g-radiation, but not to
application of Fas-antibody.
away from the ventricular zones to form distinct struc- et al., 1995; Rakic, 1995; Huttner and Brand, 1997). Clas-
sical histological studies have documented the exis-tures of thebrain (Rakic, 1988). The size of the progenitor
pool in the neuroepithelium, which determines the size tence of pyknotic clusters within neuroepithelium during
early embryogenesis (Glucksmann, 1951; Kallen, 1955),of these structures, may be modulated by several mech-
anisms, including the cell cycle kinetics of stem cells, and a reduction of these pyknotic cells is a hallmark of
Casp3 null mutation phenotypes (Kuida et al., 1996).the rate of exit of the cell cycle (asymmetric division),
and programmed cell death of progenitor cells (Caviness Similarly, we observed in the Casp9±deficient embryos
Cell
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Figure 7. Requirement of Caspase 9 for Caspase 3±like Cleavage Activity in Defined Apoptotic Pathways in Thymocytes
Wild-type (filled squares) and Casp92/2 (open circles) thymocytes were treated with various concentration of etoposide (A and E), dexametha-
sone (B and F), g-radiation (C and G), and anti-Fas antibody (D and H) for 6 hrs and assayed for cell survival (A±D) and Casp3±like cleavage
activity (E±H). Cell survival was assayed by FACS analysis of FITC-labeled Annexin V and 7-ADD stained thymocytes. Casp3±like enzymatic
activity was measured as relative fluorescent units (RFU) based on the cleavage of the fluorogenic substrate DEVD-AMC. Casp92/2 thymocytes
exhibit increased cell survival and concomitant absence of Casp3±like cleavage activity in response to etoposide, dexamethasone, and
g-radiation, but not to Fas-induced apoptosis.
a reduced cell death of neuroepithelial progenitors, indi- caused by a variety of stimuli in thymocytes. Although
the activation of caspases has been implicated to becated by histological analysis of pyknosis and TUNEL
staining of apoptotic cells (Figure 4). Therefore, as a an important mechanism during thymic selection (Clay-
ton et al., 1997), the fact that the total number and com-consequence of the failure of apoptosis, an abnormal
expansion of the proliferative pool may give rise to vari- position of thymocytes is normal in the mutant mice
makes it unlikely that Casp9 plays an indispensable roleous malformations in Casp9±deficient animals, such as
protrusion of brain mass, stenosis of ventricules, hetero- in the negative selection (Figure 6A). In contrast, Casp9±
deficient thymocytes exhibit an increased resistance totopias, invagination, and interruption of the telence-
phalic wall (Figure 3). dexamethasone, etoposide, and g-radiation; no appre-
ciable apoptosis of mutant cells was noticed at 6 hrAlthough gene disruption of either Casp9 or Casp3
causes brain malformations, the abnormality was far more after treatment, and a significant number of Casp92/2
cells were still alive at 24 hr, whereas wild-type thymo-severe in mice lacking Casp9. Thus, Casp3±deficient
fetuses rarely exhibit an overt exencephaly abnormality cytes were all dead by 24 hr. In addition, the resistance
to apoptosis is accompanied by an attenuation of DNA(Kuida et al., 1996, and unpublished observations),
whereas Casp92/2 fetuses regularly show prominent fragmentation. This suggests that Casp9, Casp3, and
caspase-activated DNA fragmentation factors (ICAD orbrain malformations. One possibility to account for the
difference in the severity of the malformation is that DFF45) may all be in a linear, nonredundant pathway
during acute apoptosis responses (Liu et al., 1997; EnariCasp9 may also activate other effector caspases, such
as Casp7, in addition to Casp3, in the nervous system. et al., 1998). Furthermore, since apoptosis and DNA
fragmentation are nevertheless found in Casp92/2 thy-Finally, while the majority of Casp9±deficient animals
die prenatally with severe brain malformations, a small mocytes after prolonged (24 hr) treatment, it is likely
that the Casp9±mediated Casp3 and DNases activationsubset of mutant mice survive to the postnatal stage
without appreciable histological abnormalities, which pathway may serve as an amplification mechanism to
accelerate the apoptotic response.indicates the existence of substitutive pathways for apo-
ptosis during brain development. The variability of phe- Interestingly, the protective effect of Casp9 deficiency
does not extend to Fas-mediated apoptosis of thymo-notypes, which was also reported in mice with targeted
disruption of the p53 or Casp3 gene, may reflect the cytes (Figure 6B). It is known that the binding of Fas-
Ligand to Fas induces trimerization of the Fas receptor,complexity of the biological mechanisms controlling
apoptosis (Sah et al., 1995; Kuida et al., 1996). which then recruits Casp8 through an FADD/MORT1
adaptor (Nagata, 1997). Casp8 and Casp9 both belong
to the same subgroup of caspases that may activateRole of Caspase 9 in Thymocytes
Our results suggest that, while Casp9 is not essential effector caspases such as Caspases 2, 3, and 7 (Nichol-
son and Thornberry, 1997). Therefore, the observedfor thymic selection, it plays a critical role in apoptosis,
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Role of Caspase 9 in Cytochrome
c±Mediated Apoptosis
Recent studies indicate that mitochondrial cytochrome
c is translocated into the cytosol in cells undergoing
apoptosis and activates DEVD-specific caspases (Kluck
et al., 1997; Yang et al., 1997; Bossy-Wetzel et al., 1998).
In an in vitro biochemical assay using human HeLa cell
lysates, it was shown that cytochrome c first binds to
the cytosolic protein Apaf1, the human Ced-4 homolog,
in the presence of dATP (Liu et al., 1996; Zou et al.,
1997). Apaf1 then interacts with Casp9 through the
shared CARD domain, and in turn recruits and activates
Casp3 through proteolysis (Li et al., 1997). In the present
study, we have extended the analysis of cytochrome
c±mediated cleavage of Casp3 using embryonic tissue
lysates (Figure 8). The absence of Casp3 cleavage in
Casp92/2 embryonic lysates, and the correction of the
functional defect by reconstitution with the deleted
gene, indicates that Casp9 is indeed an essential com-
ponent for cytochrome c±mediated caspase cascade in
vivo. In addition, we found that the cleavage of other
effector caspases in the cytochrome c±mediated reac-
tions is also dependent on Casp9 (K. K. et al., un-
published data). Together, these results indicate that
Casp9 is a crucial upstream activator of the cytochrome
c±mediated apoptotic cascade. These results suggest,
therefore, that a deficiency in cytochrome c±mediated
and Casp9±dependent apoptosis is responsible for the
in vivo phenotypes we report. It is, however, possible
that Casp9 can also be activated by other presently
unidentified upstream activators.
Release of cytochrome c from the mitochondria has
been shown to be an almost universal phenomenon
during apoptosis, while it is unclear whether the cyto-
chrome c±mediated caspase cascade is triggered only
by a few apoptotic stimuli or serves as a general ampli-
fication mechanism to accelerate cell death (Reed,
1997). A growing body of evidence has indicated that
caspases are activated not only during developmental
programmed cell death but also in a variety of human
diseases (Thompson, 1995). If cytochrome c±mediated
caspase cascade is involved in the pathogenesis pro-
cess leading to cell death, Casp9, as the crucial up-
stream activator of the caspase cascade, should be an
appropriate target for future therapeutic intervention.
Experimental Procedures
Figure 8. Absence and Reconstitution of Cytochrome c±Mediated
Generation of Caspase 9±Deficient MiceCleavage of Caspase 3 in Caspase 9±Deficient Cells
Human CASP9 cDNA was amplified by PCR from Jurkat cells using(A) Cleavage of 35S-labeled Pro-Casp3 using S-100 cytosolic frac-
CASP9-specific primers (59-ATG GAC GAA GCG GAT CGG CGGtions from E15.5 wild-type andCasp92/2 embryonic brains or thymo-
C-39 and 59-TTA TGA TGT TTT AAA GAA AAG-39). 129SV/J genomiccytes. Addition of dATP (1 mM) and/or cytochrome c (0.2 mg) is
library (Stratagene) was screened with the cDNA to obtain a mouseindicated. Cytosolic fractions from Casp92/2 cells do not cleave
Casp9 genomic clone. An 8 kb HindIII±NotI fragment containing aPro-Casp3 while the wild-type cell fractions are capable of pro-
portion encoding the pentapeptide motif conserved among Caspasecessing Pro-Casp3 (arrowheads).
family members was subcloned into pBlueScript (Stratagene). The(B) Reconstitution of in vitro±transcribed and ±translated human
resulting plasmid was digested with XbaI and blunted. EcoRI±HindIIICASP9 restores the Pro-Casp3 processing activity in cytosolic ex-
fragment of the neo gene cassette (Nakayama et al., 1993) was alsotracts of E15.5 Casp92/2 brains. The same amounts of dATP and/
blunted and ligated to the plasmid containing the mouse Casp9or cytochrome c as in (A) were used.
genome. The plasmid was then digested with XhoI and NotI and
subcloned into the tk cassette vector (Nakayama et al., 1993). The
construct was linearized by NotI and transfected into W9.5 ES cellspreferential resistance to dexamethasone versus Fas-
(a gift from Dr. S. J. Abbondanzo, Roche Research Center). Clones
induced apoptosis implicates a functional diversifica- resistant to G418 and gancyclovir were selected, and homologous
tion of caspase cascades, depending on the external recombination was confirmed by Southern blotting. One out of 32
clones screened was positive for homologous recombination, andstimulus.
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single integration of the construct was verified by hybridization with Assay for Cleavage of Caspase 3
Full-length human CASP3 cDNA was transcribed and translatedthe neo-specific probe. Chimeric mice were generated by injection
of this clone into C57BL/6 blastocysts. The resulting male chimera using TNT quick-coupled transcription/translation system (Pro-
mega) and 35S-methionine (Amersham). To generate the recombi-mice were bred to C57BL/6 females to obtain heterozygous mice.
Interbreeding of the heterozygous mice was performed to generate nant Casp9, full-length Casp9 cDNA was translated using the same
system. S-100 cytosolic fractions were obtained as described byCasp9±deficient mice.
Liu et al. (1996). An aliquot of in vitro±translated Casp3 was incu-
bated with 20 mg of S-100 cytosolic fraction in the presence of 1RT-PCR Analysis of Caspase 9 mRNA
Total RNA was isolated from the kidney by Trizol reagent (GIBCO- mM of additional MgCl2 with or without cytochrome c or dATP at
BRL). Five micrograms of total RNA was reverse-transcribed using 308C for 1 hr in a final volume of 20 ml. For reconstitution of Casp9
the superscript preamplification system (GIBCO-BRL), and the re- activity, 5 ml of the translated reaction or reticulocyte lysate was
sulting templates were subjected to a PCR reaction with Casp9- added to the reaction. At the end of incubation, 7 ml of 43 SDS
specific primers (59-GCC ATG GAC GAA GCG GAT CGG CGG-39 sample buffer was added to each reaction and samples electropho-
and 59-GGC CTG GAT GAA GAA GAG CTT GGG-39) or primers resed on a 16% SDS-PAGE gel. Gels were dried and exposed to a
specific for g-actin. phosphoimaging plate and analyzed by Fuji BAS-1500 bio-image
analyzer.
Northern Blot Analysis
Poly(A)1 RNA blots (Clontech) were hybridized overnight with ran-
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